Canadian startup helps scientists
The Toronto lab works with all the major pharmaceutical companies.
Toronto-based startup BenchSci uses artificial intelligence to help pharmaceutical companies accelerate research and development. BenchSci recently received CAD 95 million in funding for its research.
Company executives have already announced that they are ready to use this capital to expand their artificial intelligence-based drug development platform. BenchSci claims that their ASCEND software decisively enables scientists to increase the success of research.
Additional investments, support from regular sponsors, and Nobel Peace Prize winner Al Gore's Generation Investment Management brought the total funding to CAD 218 million.
BenchSci CEO and co-founder Liran Belenzon hailed the investment as "validation of the work its team has done and the traction that BenchSci has generated with large pharma and biotech firms around the world."
Today BenchSci works with 16 of the 20 largest pharmaceutical companies in the world. Among them are giants like Moderna, AstraZeneca, Sanofi. BenchSci's connections also include about 4 500 research centers around the Globe.
The full article is only available to members of the Immigrant.Today community. Log in to your account to read it for free.
